BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32597709)

  • 1. Broad-spectrum antibiotics alter the microbiome, increase intestinal
    Maselli KM; Gee K; Isani M; Fode A; Schall KA; Grikscheit TC
    Am J Physiol Gastrointest Liver Physiol; 2020 Aug; 319(2):G212-G226. PubMed ID: 32597709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remnant Intestinal Length Defines Intestinal Adaptation and Hepatic Steatosis: Two Zebrafish Models.
    Maselli KM; Gee K; Grikscheit TC
    J Surg Res; 2020 Nov; 255():86-95. PubMed ID: 32543383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease.
    Pereira-Fantini PM; Lapthorne S; Joyce SA; Dellios NL; Wilson G; Fouhy F; Thomas SL; Scurr M; Hill C; Gahan CG; Cotter PD; Fuller PJ; Hardikar W; Bines JE
    J Hepatol; 2014 Nov; 61(5):1115-25. PubMed ID: 24999016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preventive effect of recombinant human hepatocyte growth factor for hepatic steatosis in a rat model of short bowel syndrome.
    Yano K; Sugita K; Muto M; Matsukubo M; Onishi S; Kedoin C; Matsui M; Murakami M; Harumatsu T; Yamada K; Yamada W; Kumagai K; Ido A; Kaji T; Ieiri S
    J Pediatr Surg; 2022 Jul; 57(7):1286-1292. PubMed ID: 35396090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.
    Cao Y; Xiao Y; Zhou K; Yan J; Wang P; Yan W; Cai W
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G108-G115. PubMed ID: 30920307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt signaling inhibition by monensin results in a period of Hippo pathway activation during intestinal adaptation in zebrafish.
    Isani MA; Gee K; Schall K; Schlieve CR; Fode A; Fowler KL; Grikscheit TC
    Am J Physiol Gastrointest Liver Physiol; 2019 Jun; 316(6):G679-G691. PubMed ID: 30896968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult zebrafish intestine resection: a novel model of short bowel syndrome, adaptation, and intestinal stem cell regeneration.
    Schall KA; Holoyda KA; Grant CN; Levin DE; Torres ER; Maxwell A; Pollack HA; Moats RA; Frey MR; Darehzereshki A; Al Alam D; Lien C; Grikscheit TC
    Am J Physiol Gastrointest Liver Physiol; 2015 Aug; 309(3):G135-45. PubMed ID: 26089336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farnesoid X Receptor Agonist Treatment Alters Bile Acid Metabolism but Exacerbates Liver Damage in a Piglet Model of Short-Bowel Syndrome.
    Pereira-Fantini PM; Lapthorne S; Gahan CGM; Joyce SA; Charles J; Fuller PJ; Bines JE
    Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):65-74. PubMed ID: 28560290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic-driven intestinal dysbiosis in pediatric short bowel syndrome is associated with persistently altered microbiome functions and gut-derived bloodstream infections.
    Thänert R; Thänert A; Ou J; Bajinting A; Burnham CD; Engelstad HJ; Tecos ME; Ndao IM; Hall-Moore C; Rouggly-Nickless C; Carl MA; Rubin DC; Davidson NO; Tarr PI; Warner BB; Dantas G; Warner BW
    Gut Microbes; 2021; 13(1):1940792. PubMed ID: 34264786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver steatosis induced by small bowel resection is prevented by oral vancomycin.
    Barron LK; Gayer CP; Roberts A; Golden JM; Aladegbami BG; Guo J; Erwin CR; Warner BW
    Surgery; 2016 Dec; 160(6):1485-1495. PubMed ID: 27592213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel effect of glucagon-like peptide-2 for hepatocellular injury in a parenterally fed rat model of short bowel syndrome.
    Yano K; Kaji T; Onishi S; Machigashira S; Nagai T; Harumatsu T; Yamada K; Yamada W; Muto M; Nakame K; Mukai M; Ieiri S
    Pediatr Surg Int; 2019 Dec; 35(12):1345-1351. PubMed ID: 31555865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 4 is critical for the development of resection-associated hepatic steatosis.
    Barron LK; Bao JW; Aladegbami BG; Colasanti JJ; Guo J; Erwin CR; Warner BW
    J Pediatr Surg; 2017 Jun; 52(6):1014-1019. PubMed ID: 28351520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short bowel syndrome results in increased gene expression associated with proliferation, inflammation, bile acid synthesis and immune system activation: RNA sequencing a zebrafish SBS model.
    Schall KA; Thornton ME; Isani M; Holoyda KA; Hou X; Lien CL; Grubbs BH; Grikscheit TC
    BMC Genomics; 2017 Jan; 18(1):23. PubMed ID: 28118819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.
    Jiang C; Xie C; Li F; Zhang L; Nichols RG; Krausz KW; Cai J; Qi Y; Fang ZZ; Takahashi S; Tanaka N; Desai D; Amin SG; Albert I; Patterson AD; Gonzalez FJ
    J Clin Invest; 2015 Jan; 125(1):386-402. PubMed ID: 25500885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short bowel syndrome (SBS)-associated alterations within the gut-liver axis evolve early and persist long-term in the piglet model of short bowel syndrome.
    Pereira-Fantini PM; Bines JE; Lapthorne S; Fouhy F; Scurr M; Cotter PD; Gahan CG; Joyce SA
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1946-1955. PubMed ID: 27037739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Central Role for Lipocalin-2 in the Adaptation to Short-Bowel Syndrome Through Down-Regulation of IL22 in Mice.
    Zhang A; Sodhi CP; Wang M; Shores DR; Fulton W; Prindle T; Brosten S; O'Hare E; Lau A; Ding H; Jia H; Lu P; White JR; Hui J; Sears CL; Hackam DJ; Alaish SM
    Cell Mol Gastroenterol Hepatol; 2020; 10(2):309-326. PubMed ID: 32330729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fecal Microbiome in Pediatric Patients With Short Bowel Syndrome.
    Davidovics ZH; Carter BA; Luna RA; Hollister EB; Shulman RJ; Versalovic J
    JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1106-1113. PubMed ID: 26059898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R-Spondin1 enhances wnt signaling and decreases weight loss in short bowel syndrome zebrafish.
    Maselli KM; Levin G; Gee KM; Leeflang EJ; Carreira ACO; Sogayar MC; Grikscheit TC
    Biochem Biophys Rep; 2021 Mar; 25():100874. PubMed ID: 33437880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No Gut No Gain! Enteral Bile Acid Treatment Preserves Gut Growth but Not Parenteral Nutrition-Associated Liver Injury in a Novel Extensive Short Bowel Animal Model.
    Villalona G; Price A; Blomenkamp K; Manithody C; Saxena S; Ratchford T; Westrich M; Kakarla V; Pochampally S; Phillips W; Heafner N; Korremla N; Greenspon J; Guzman MA; Kumar Jain A
    JPEN J Parenter Enteral Nutr; 2018 Nov; 42(8):1238-1251. PubMed ID: 29701901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal lengthening and reversed segment in a piglet short bowel syndrome model.
    Koffeman GI; Hulscher JB; Schoots IG; van Gulik TM; Heij HA; van Gemert WG
    J Surg Res; 2015 May; 195(2):433-43. PubMed ID: 25819769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.